Novo Nordisk A/S (NVO)

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Q: What's the best way to play the GLP-1/Semaglutide bandwagon now that the WHO is encouraging its use as a way to better health through weight loss?

Read Answer Asked by John on December 03, 2025

Q: Has NVO fallen to a level you see as attractive?

Read Answer Asked by Kim on November 24, 2025

Salesforce Inc. (CRM $265.26)
- $265.26 P/E (TTM): 35.42X Cap: $248.54B
- View CRM Profile
- View Questions on CRM
UnitedHealth Group Incorporated (DE) (UNH $327.58)
- $327.58 P/E (TTM): 17.09X Cap: $296.73B
- View UNH Profile
- View Questions on UNH
Novo Nordisk A/S (NVO $52.56)
- $52.56 P/E (TTM): 14.71X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
The Trade Desk Inc. (TTD $38.12)
- $38.12 P/E (TTM): 43.82X Cap: $18.43B
- View TTD Profile
- View Questions on TTD
Crocs Inc. (CROX $90.61)
- $90.61 P/E (TTM): 29.51X Cap: $4.70B
- View CROX Profile
- View Questions on CROX
Axon Enterprise Inc. (AXON $591.15)
- $591.15 P/E (TTM): 187.43X Cap: $46.64B
- View AXON Profile
- View Questions on AXON
e.l.f. Beauty Inc. (ELF $79.76)
- $79.76 P/E (TTM): 56.17X Cap: $4.75B
- View ELF Profile
- View Questions on ELF
Duolingo Inc. (DUOL $180.69)
- $180.69 P/E (TTM): 22.9X Cap: $8.35B
- View DUOL Profile
- View Questions on DUOL

Q: What would be your US stocks for tax loss selling?
Thank you so much. Lorraine

Read Answer Asked by Lorraine on November 24, 2025